For example, TP53 mutations mediate tumor immune escape [20], including attenuation of T cell and natural killer (NK) cell response and promotion of immunosuppressive myeloid-derived suppressor cells (MDSC), tumor-associated macrophages (TAMs) and regulatory T cells (Treg) [20–22]. This evidence concerns the gene TP53 and neoplasm.